Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Leyden

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
The Journal of Dermatological Treatment|March 8, 2016
How does our increased understanding of the role of inflammation and innate immunity in acne impact treatment approaches?James Leyden
Journal of Drugs in Dermatology : JDD|April 15, 2008
New developments in topical antimicrobial therapy for acneJames Leyden
The Journal of Dermatological Treatment|March 8, 2016
Recent advances in the use of adapalene 0.1%/benzoyl peroxide 2.5% to treat patients with moderate to severe acneJames Leyden
International Journal of Dermatology|February 22, 2011
The mechanism of action and clinical benefits of soy for the treatment of hyperpigmentationJames Leyden, Warren Wallo
Cutis|February 13, 2004
Mechanism-based selection of pharmacologic agents for rosaceaAlan Shalita, James Leyden
Medical Hypotheses|April 16, 2008
The role of the basal ganglia in data processingJames Leyden, Tim Kleinig
Journal of Drugs in Dermatology : JDD|March 17, 2017
Prevalence and Risk Factors of Acne Scarring Among Patients Consulting Dermatologists in the USAJerry Tan, Sewon Kang, James Leyden
Stroke|February 6, 2014
Clinical associations and causes of convexity subarachnoid hemorrhageAshan Khurram, Timothy Kleinig, James Leyden
Skinmed|September 6, 2007
Anti-inflammatory dose doxycycline (40 mg controlled-release) confers maximum anti-inflammatory efficacy in rosaceaKlaus Theobald, Mark Bradshaw, James Leyden
Journal of Drugs in Dermatology : JDD|December 31, 2004
Facial tolerability of topical retinoid therapyJames Leyden, Gary Grove, Charles Zerweck
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
The Journal of Dermatological Treatment|March 8, 2016
How does our increased understanding of the role of inflammation and innate immunity in acne impact treatment approaches?James Leyden
Journal of Drugs in Dermatology : JDD|April 15, 2008
New developments in topical antimicrobial therapy for acneJames Leyden
The Journal of Dermatological Treatment|March 8, 2016
Recent advances in the use of adapalene 0.1%/benzoyl peroxide 2.5% to treat patients with moderate to severe acneJames Leyden
International Journal of Dermatology|February 22, 2011
The mechanism of action and clinical benefits of soy for the treatment of hyperpigmentationJames Leyden, Warren Wallo
Cutis|February 13, 2004
Mechanism-based selection of pharmacologic agents for rosaceaAlan Shalita, James Leyden
Medical Hypotheses|April 16, 2008
The role of the basal ganglia in data processingJames Leyden, Tim Kleinig
Journal of Drugs in Dermatology : JDD|March 17, 2017
Prevalence and Risk Factors of Acne Scarring Among Patients Consulting Dermatologists in the USAJerry Tan, Sewon Kang, James Leyden
Stroke|February 6, 2014
Clinical associations and causes of convexity subarachnoid hemorrhageAshan Khurram, Timothy Kleinig, James Leyden
Skinmed|September 6, 2007
Anti-inflammatory dose doxycycline (40 mg controlled-release) confers maximum anti-inflammatory efficacy in rosaceaKlaus Theobald, Mark Bradshaw, James Leyden
Journal of Drugs in Dermatology : JDD|December 31, 2004
Facial tolerability of topical retinoid therapyJames Leyden, Gary Grove, Charles Zerweck
Pageof 4